Literature DB >> 2225992

The malignancy-sarcoidosis syndrome.

J S Suen1, M S Forse, R H Hyland, C K Chan.   

Abstract

In a retrospective review of six patients with malignancy preceding sarcoidosis, we found four cases of malignant lymphoproliferative disease (LD) and one case each of ovarian cancer and breast cancer. The median interval from onset or relapse of malignancy to sarcoidosis was nine months. Of the four patients with LD, sarcoidosis appeared within six months of termination of chemotherapy for three of the patients and 15 months after allogeneic bone marrow transplantation for the fourth patient. At the time of diagnosis of sarcoidosis, there was no clinical or pathologic evidence of malignancy in the chest. We conclude that in contradistinction to the previously described syndrome of sarcoidosis preceding LD, there exists a syndrome of sarcoidosis following malignancy with or without chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2225992     DOI: 10.1378/chest.98.5.1300

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

1.  A patient presenting with generalised lympadenopathy--sarcoidosis, lymphoma or tuberculosis?

Authors:  Nayia Petousi; Jovin Mathew; Enson C Thomas
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  Two cases of sarcoidosis-lymphoma syndrome.

Authors:  Nada Suvajdzic; Branislava Milenkovic; Maja Perunicic; Jelena Stojsic; Snezana Jankovic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 3.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Reumatismo       Date:  2017-05-22

4.  Breast Cancer and Sarcoidosis: Case Series and Review of the Literature.

Authors:  Jacob Chen; Robert Carter; Daniel Maoz; Ana Tobar; Eran Sharon; Franklin Greif
Journal:  Breast Care (Basel)       Date:  2015-04       Impact factor: 2.860

5.  Negative Predictive Value of Granulomas on EBUS-TBNA in Suspected Extrathoracic Malignancy.

Authors:  Christina R Bellinger; Deepankar Sharma; Jimmy Ruiz; Graham Parks; Travis Dotson; Edward F Haponik
Journal:  Lung       Date:  2016-04-25       Impact factor: 2.584

Review 6.  Epidemiology of sarcoidosis: current findings and future directions.

Authors:  Elizabeth V Arkema; Yvette C Cozier
Journal:  Ther Adv Chronic Dis       Date:  2018-08-24       Impact factor: 5.091

7.  Risk of Malignancy Among Patients With Sarcoidosis: A Population-Based Cohort Study.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-16       Impact factor: 4.794

8.  FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment.

Authors:  Kentaro Inoue; Ryoi Goto; Hideo Shimomura; Hiroshi Fukuda
Journal:  Springerplus       Date:  2013-03-15

9.  Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma.

Authors:  Baldeep Wirk
Journal:  Clin Med Insights Case Rep       Date:  2010-08-04

10.  Uterine sarcoidosis: a rare extrapulmonary site of sarcoidosis.

Authors:  Creticus P Marak; Narendrakumar Alappan; Amit Chopra; Olena Dorokhova; Sumita Sinha; Achuta K Guddati
Journal:  Case Rep Rheumatol       Date:  2013-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.